News and Announcements
Biorithm featured in Medical Festival Asia 2020
- Published February 26, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Biorithm’s novel femom remote monitoring system was featured at the Medical Festival Asia in two panels discussing new technologies in healthcare and women’s health.
The first panel featured Prof Basky Thilaganathan, Professor of fetal medicine at St George’s University, London, discussing the need for new technologies to address gaps in care in obstetrics and how femom could provide both clinical as well as workflow improvements in the NHS.
The second panel featuring Dr Deboarh Fox, Senior Lecturer for Midwifery at UTS, Sydney, Dr Christina Low, MD for Singapore Medical Group and Amrish Nair, Co-Founder of Biorithm, discussed how to keep obstetrics care human in the age of technology. Amrish amplified Biorithm’s mission to improve the patient experience and using digital as a tool to improve quality of care rather than replace care altogether.
Through these panels, Biorithm aims to foster improvement of obstetric care by engaging to top clinical minds in the field.
About Biorithm
Biorithm provides innovative maternal-fetal connected care solution to improve pregnancy outcomes for patients and healthcare providers.
Forging new frontiers in pregnancy care, Biorithm has developed cutting edge analytic software together with medical-grade abdominal ECG wearable designed for remote monitoring of maternal & fetal physiological parameters.
Our unique solution allows accurate monitoring of a wide range of vital pregnancy data, empowering patient and clinicians to identify early signs of maternal-fetal complication for timely intervention while reducing the cost of care.
Founded by doctors and engineers, Biorithm is a medical technology start-up spun-off from Nanyang Technological University in Singapore. We believe that comprehensive maternal healthcare should leverage the power of digital health and advanced sensors to address individual patient and clinicians needs, enhance data-driven decisions, complication prevention, and provide access to affordable and preventive care.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
